ResearcherUniversity of FloridaActive in the last 2 years
Jinmai Jiang
Matched on ORCID iD 0000-0002-2418-6781; OpenAlex author ID A5110253988. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 7
- Renin-angiotensin-aldosterone system inhibitors and risk of pancreatic cancer in older adults: A target trial emulation. Co-author DOI 10.1002/ijc.70438↗
- Nanomaterial isolated extracellular vesicles enable high precision identification of tumor biomarkers for pancreatic cancer liquid biopsy. Co-author DOI 10.1186/s12951-025-03527-3↗
- Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. First author DOI 10.1038/s41598-019-47566-x↗
- miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal. Co-author DOI 10.1007/s10142-016-0512-1↗
- Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ncrna3030024↗
- Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.10242↗
- miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Co-author DOI 10.1016/j.bbrc.2011.02.065↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thomas D. Schmittgen · 7 shared papers, 2011–2026 · strength 0.83
- Paper Renin-angiotensin-aldosterone system inhibitors and risk of pancreatic cancer in older adults: A target trial emulation. DOI 10.1002/ijc.70438↗
- Paper Nanomaterial isolated extracellular vesicles enable high precision identification of tumor biomarkers for pancreatic ca… DOI 10.1186/s12951-025-03527-3↗
- Paper Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. DOI 10.1038/s41598-019-47566-x↗
- Ana Clara P. Azevedo‐Pouly · 4 shared papers, 2016–2019 · strength 0.28
- Paper Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. DOI 10.1038/s41598-019-47566-x↗
- Paper miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/… DOI 10.1007/s10142-016-0512-1↗
- Paper Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreati… DOI 10.3390/ncrna3030024↗
- Dhruvitkumar S. Sutaria · 4 shared papers, 2016–2019 · strength 0.28
- Paper Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. DOI 10.1038/s41598-019-47566-x↗
- Paper miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/… DOI 10.1007/s10142-016-0512-1↗
- Paper Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreati… DOI 10.3390/ncrna3030024↗
- Tianze Jiao · 1 shared paper, 2026 · strength 0.27
- Fanxing Du · 1 shared paper, 2026 · strength 0.27
- Thomas J. George · 1 shared paper, 2026 · strength 0.27
- Zachary Greenberg · 1 shared paper, 2025 · strength 0.26
- Steven J. Hughes · 1 shared paper, 2025 · strength 0.26
- Mei He · 1 shared paper, 2025 · strength 0.26
- Paul J. Grippo · 2 shared papers, 2017–2019 · strength 0.15
- Daniel J. Brackett · 3 shared papers, 2011–2017 · strength 0.15
- Paper Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreati… DOI 10.3390/ncrna3030024↗
- Paper Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. DOI 10.18632/oncotarget.10242↗
- Paper miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. DOI 10.1016/j.bbrc.2011.02.065↗
- Xiuli Liu · 1 shared paper, 2019 · strength 0.08
- Georgina E. Mancinelli · 1 shared paper, 2019 · strength 0.08
- Jun Lü · 1 shared paper, 2019 · strength 0.08
- Carolina Torres · 1 shared paper, 2019 · strength 0.08
- Julie Bray · 1 shared paper, 2019 · strength 0.08
- George A. Călin · 1 shared paper, 2016 · strength 0.05
- Jong Kook Park · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.